| Results summary | View all lists in L2L MDB | View all genes in A07E.profile.ud50 |
|
Upregulated by DAC treatment in at least one of four pancreatic cancer cell lines, but not in normal (HPDE) cells enrichment: 2.47-fold |
![]() |
||||||||||||
| Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
| 211731_X_AT | SSX3 | R | synovial sarcoma, X breakpoint 3 | ||||||||||
| 220650_S_AT | SLC9A5 | T | solute carrier family 9 (sodium/hydrogen exchanger), member 5 | ||||||||||
| 206544_X_AT | SMARCA2 | G | R | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 | |||||||||
| 202861_AT | PER1 | R | S | period homolog 1 (Drosophila) | |||||||||
| 202435_S_AT | CYP1B1 | E | cytochrome P450, family 1, subfamily B, polypeptide 1 | ||||||||||
| 36829_AT | PER1 | R | S | period homolog 1 (Drosophila) | |||||||||
| 219832_S_AT | HOXC13 | D | R | homeobox C13 | |||||||||
| 202436_S_AT | CYP1B1 | E | cytochrome P450, family 1, subfamily B, polypeptide 1 | ||||||||||